OrtizA.Apoptotic regulatory proteins in renal injury.Kidney Int2000; 58: 467–85.
2.
OrtizA., JustoP., CatalánM.P., SanzA.B., LorzC., EgidoJ.Apoptotic cell death in renal injury: The rationale for intervention.Curr Drug Targets Immune Endocr Metabol Disord2002; 2: 181–92.
3.
Yanez-MoM., Lara-PezziE., SelgasR., Ramirez-HuescaM., Dominguez-JimenezC., Jimenez-HeffernanJ.A.Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells.N Engl J Med2003; 348: 403–13.
CatalánM.P., EstebanJ., SubiráD., EgidoJ., OrtizA.Inhibition of caspases improves bacterial clearance in experimental peritonitis.Perit Dial Int2003; 23: 123–6.
6.
CatalanM.P., SubiráD., ReyeroA., SelgasR., OrtizA., EgidoJ.Regulation of apoptosis by lethal cytokines in human mesothelial cells.Kidney Int2003; 64: 321–30.
7.
ZhengZ., YeR., YuX., BergstromJ., LindholmB.Peritoneal dialysis solutions disturb the balance of apoptosis and proliferation of peritoneal cells in chronic dialysis model.Adv Perit Dial2001; 17: 53–7.
8.
GotloibL., WajsbrotV., ShostakA.Mesothelial dysplastic changes and lipid peroxidation induced by 7.5% icodextrin.Nephron2002; 92: 142–55.
9.
GotloibL., ShostakA., WajsbrotV., KushnierR.High glucose induces a hypertrophic, senescent mesothelial cell phenotype after long in vivo exposure.Nephron1999; 82: 164–73.
10.
DesmouliereA., RedardM., DarbyI., GabbianiG.Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar.Am J Pathol1995; 146: 56–66.
11.
ChavakisE., DimmelerS.Regulation of endothelial cell survival and apoptosis during angiogenesis.Arterioscler Thromb Vasc Biol2002; 22: 887–93.
12.
RathmellJ.C., ThompsonC.B.Pathways of apoptosis in lymphocyte development, homeostasis, and disease.Cell2002; 109(Suppl): S97–107.
13.
HotchkissR.S., TinsleyK.W., SwansonP.E., ChangK.C., CobbJ.P., BuchmanT.G.Prevention of lymphocyte cell death in sepsis improves survival in mice.Proc Natl Acad Sci USA1999; 96: 14541–6.
14.
HotchkissR.S., ChangK.C., SwansonP.E., TinsleyK.W., HuiJ.J., KlenderP.Caspase inhibitors improve survival in sepsis: A critical role of the lymphocyte.Nat Immunol2000; 1: 496–501.
15.
CoopersmithC.M., ChangK.C., SwansonP.E., TinsleyK.W., StrombergP.E., BuchmanT.G.Overexpression of Bcl-2 in the intestinal epithelium improves survival in septic mice.Crit Care Med2002; 30: 195–201.
16.
SavillJ., DransfieldI., GregoryC., HaslettC.A blast from the past: Clearance of apoptotic cells regulates immune responses.Nat Rev Immunol2002; 2: 965–75.
17.
LauberK., BohnE., KroberS.M., XiaoY.J., BlumenthalS.G., LindemannR.K.Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal.Cell2003; 113: 717–30.
18.
FeterowskiC., WeighardtH., EmmanuilidisK., HartungT., HolzmannB.Immune protection against septic peritonitis in endotoxin-primed mice is related to reduced neutrophil apoptosis.Eur J Immunol2001; 31: 1268–77.
19.
CatalánM.P., ReyeroA., EgidoJ., OrtizA.Acceleration of neutrophil apoptosis by glucose-containing peritoneal dialysis solutions: Role of caspases.J Am Soc Nephrol2001; 12: 2442–9.
20.
BellinganG.J., CaldwellH., HowieS.E., DransfieldI., HaslettC.In vivo fate of the inflammatory macrophage during the resolution of inflammation: Inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes.J Immunol1996; 157: 2577–85.
21.
JinH.M., DiY.D., XuQ.J.Effects of commercial glucose-based peritoneal dialysates on peripheral blood phagocytes apoptosis.Perit Dial Int1999; 19(Suppl 2): S388–93.
22.
ThomasG.L., YangB., WagnerB.E., SavillJ., El NahasA.M.Cellular apoptosis and proliferation in experimental renal fibrosis.Nephrol Dial Transplant1998; 13: 2216–26.
23.
XiaC., XuZ., YuanX., UematsuK., YouL., LiK.Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides.Mol Cancer Ther2002; 1: 687–94.
24.
SmytheW.R., MohuiddinI., OzveranM., CaoX.X.Antisense therapy for malignant mesothelioma with oligonucleotides targeting the bcl-xl gene product.J Thorac Cardiovasc Surg2002; 123: 1191–8.
25.
MohiuddinI., CaoX., FangB., NishizakiM., SmytheW.R.Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-xl down-regulation in mesothelioma.Cancer Gene Ther2001; 8: 547–54.
26.
PataerA., SmytheW.R., YuR., FangB., McDonnellT., RothJ.A.Adenovirus-mediated Bak gene transfer induces apoptosis in mesothelioma cell lines.J Thorac Cardiovasc Surg2001; 121: 61–7.
27.
AshkenaziA., DixitV.M.Death receptors: Signaling and modulation.Science1998; 281: 1305–8.
28.
OrtizA., LorzC., EgidoJ.New kids in the block: The role of FasL and Fas in kidney damage.J Nephrol1999; 12: 150–8.
29.
PlumJ., LordnejadM.R., GrabenseeB.Effect of alternative peritoneal dialysis solutions on cell viability, apoptosis/necrosis and cytokine expression in human monocytes.Kidney Int1998; 54: 224–35.
30.
CendorogloM., SundaramS., GrovesC., UcciA.A., JaberB.L., PereiraB.J.Necrosis and apoptosis of polymorphonuclear cells exposed to peritoneal dialysis fluids in vitro.Kidney Int1997; 52: 1626–34.
31.
ZhengZ.H., YeR.G., BergstromJ., LindholmB.Effect of dialysate composition on the apoptosis and proliferation of human peritoneal mesothelial cells and protein expression of Fas and c-Myc.Adv Perit Dial2000; 16: 31–5.
PlumJ., RazeghiP., LordnejadR.M., PerniokA., FleischM., FusshollerA.Peritoneal dialysis fluids with a physiologic pH based on either lactate or bicarbonate buffer – effects on human mesothelial cells.Am J Kidney Dis2001; 38: 867–75.
34.
LetaiA., BassikM.C., WalenskyL.D., SorcinelliM.D., WeilerS., KorsmeyerS.J.Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics.Cancer Cell2002; 2: 183–92.
35.
PuthalakathH., StrasserA.Keeping killers on a tight leash: Transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins.Cell Death Differ2002; 9: 505–12.
36.
AdamsJ.M., CoryS.Life-or-death decisions by the Bcl-2 protein family.Trends Biochem Sci2001; 26: 61–6.
37.
LoefflerM., KroemerG.The mitochondrion in cell death control: Certainties and incognita.Exp Cell Res2000; 256: 19–26.
38.
FerriK.F., KroemerG.Organelle-specific initiation of cell death pathways.Nat Cell Biol2001; 3: E255–63.
LassusP., Opitz-ArayaX., LazebnikY.Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization.Science2002; 297: 1352–4.
41.
Garcia-CalvoM., PetersonE.P., LeitingB., RuelR., NicholsonD.W., ThornberryN.A.Inhibition of human caspases by peptide-based and macromolecular inhibitors.J Biol Chem1998; 273: 32608–13.
42.
JohnsonD.E.Noncaspase proteases in apoptosis.Leukemia2000; 14: 1695–703.
43.
VerhagenA.M., CoulsonE.J., VauxD.L.Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs.Genome Biol (Serial online) 2001 July 05; 2(7): REVIEWS3009. Available from: http://genomebiology.com/2001/2/7/reviews/3009